Conference abstract · 7 Nov 2016
EditorialPublished 2015
Regulations in Development of Biosimilars
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hitt Sharma, Sameer Parekh and Sunil Shewale PDF Share this article
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 2013
A Comparision of US, Europe, Japan and India Biosimilar Regulations
Conference abstract · 23 Nov 2012
Biosimilar regulations in India: Current scenario
Editorial · 2012
Biowaivers and Biosimilars Reinforcing Intent and Content of Researchers and Regulators
Conference abstract
EU biosimilar regulations: An analysis of the data which has underpinned the approval of biosimilars granted marketing authorizations in Europe
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hitt Sharma”
- BylineArticles whose byline prints “Sameer Parekh”
- BylineArticles whose byline prints “Sunil Shewale”

